PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Inpharmatis Team Participated in the Russian Healthcare Forum
Experts from Inpharmatis have visited the conference "Pharmaceutical provision - 360 degrees" and the exhibition of manufacturers of medical devices and pharmaceuticals.
The conference included a public session with several of the government agencies, such as the Ministry of Industry and Trade, Ministry of Health, Roszdravnadzor, as well as pharmaceutical companies and industry associations making presentations to the panel.
The exhibition for medical products has brought together the entire industry to present the latest developments of Russian and international companies, including artificial intelligence and recent innovations in diagnostic tools.
Representatives of the Inpharmatis discussed with manufacturers of pharmaceutical products and medical devices the opportunities and framework for cooperation in the field of regulatory affairs, pharmacovigilance, electronic quality management system. Since from 2022 the registration of medical devices will proceed only under the Eurasian Economic Union (EAEU) rules, Inpharmatis is ready to offer its clients a full range of services in accordance with Eurasian legislation. The company has already delivered successful projects on bringing dossiers in line with the EAEU requirements.
CEO of Inpharmatis Dr. Polina Dombure noted, “materiovogilance is one of the main trends in the regulation of medical devices all over the world, including the European Union. We consider it to be one of the most promising for the development of the portfolio of services".
For 15 years, the Inpharmatis group has been successfully providing a full range of consulting services for pharmaceutical companies in the European Union, the EAEU and the CIS. Inpharmatis team offers the best regulatory expertise from around Europe, combined with deep, local knowledge of all markets in this dynamic region.
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022
Pharma 4.0: от управления на основе документов к решениям, основанным на данныхJanuary 18, 2022
New Inpharmatis Russian Office Phone NumberJanuary 05, 2022
Изменение контактных данных российского офиса InpharmatisJanuary 05, 2022
Inpharmatis Team Participated in the Russian Healthcare ForumDecember 16, 2021
Inpharmatis принял участие в работе форума «Российская неделя здравоохранения»December 16, 2021